THE APEX TIMES
CVS Health Foundation pledges $1 million in Rhode Island grants through its Hometown Fund
The foundation says the funding will support 20 nonprofits focused on access to health care, food security, stable housing and other daily factors that affect wellbeing.
CVS Health’s philanthropic arm, the CVS Health Foundation, is investing $1 million in Rhode Island nonprofits to address community health needs, including access to care, food insecurity and stable housing. The grants are being distributed through the foundation’s Hometown Fund program and will support 20 local organizations statewide, according to a company announcement published by PR Newswire on June 25, 2026.
The foundation said this year’s Hometown Fund awards are intended to help organizations meet practical barriers that can keep people from staying healthy. It pointed to work that expands access to health care, addresses hunger and food insecurity, increases availability of stable housing, and improves community health more broadly across Rhode Island.
CVS Health Foundation President Jenny McColloch said in the announcement that the grants target “communities our colleagues call home,” with a focus on the everyday factors that shape wellbeing. She framed the Hometown Fund effort as investing in Rhode Island nonprofits that “meet people where they are,” helping individuals and families obtain health care and the supports needed to remain healthy.
One recipient highlighted by the foundation is Aldersbridge Communities, which it described as working with older adults by connecting affordable housing with essential health care services. The announcement said the organization provides a continuum of care, including independent living, assisted living and memory care assisted living, and that the Hometown Fund support is meant to strengthen those services so more older adults can age with stability and support.
Beyond the specific example of Aldersbridge, the announcement did not list every organization receiving funding or break out individual grant amounts by recipient. It also did not provide detailed performance targets tied to the grants, such as the number of people expected to receive services or specific outcomes the nonprofits will be measured against.
The move reflects a broader pattern in U.S. health care, where major providers and insurers increasingly tie community investment to social determinants of health, such as housing and nutrition. For CVS Health, which operates pharmacies, a large retail presence and other health services, these kinds of local partnerships can complement clinical operations by targeting upstream issues that influence health utilization and prevention.
The foundation did not disclose where the $1 million is sourced from in terms of funding structure, nor did it describe whether grants are restricted to particular geographies beyond being within Rhode Island. It also did not clarify whether the 20 organizations were selected through an application process, a competitive review, or another internal screening method.
Looking ahead, the next question for readers will be how the funded nonprofits translate the money into services and measurable impacts, and whether CVS Health Foundation publishes follow-up reporting on outcomes in Rhode Island later in the year. The foundation’s next Hometown Fund announcements in other states may also provide clues on whether it is using similar program themes and grant structures across its portfolio.
Why It Matters
- Community health grants can influence the health care ecosystem by addressing non-medical needs that affect whether people can access care and maintain wellness.
- For large health insurers and retailers, local investment initiatives can help build relationships with service providers that address social determinants of health.
- The choice to emphasize food, housing and daily support indicates ongoing alignment between philanthropy and the broader health sector’s shift toward upstream prevention.
- The lack of recipient-by-recipient detail in the announcement may limit near-term visibility into how funds are allocated and what outcomes are prioritized.
Sources
Key Facts
- The CVS Health Foundation announced $1 million in grants for Rhode Island nonprofits through its Hometown Fund program.
- The awards will support 20 organizations statewide.
- The foundation said the funding targets barriers tied to everyday wellbeing, including access to health care, food insecurity and stable housing.
- CVS Health Foundation President Jenny McColloch said the program focuses on meeting communities where people are.
- The announcement highlighted Aldersbridge Communities as a recipient providing housing linked with health care services for older adults.
Healthcare Related
Eli Lilly to buy Merida Biosciences in up-to $2.875 billion cash deal, betting on an expanded autoimmune pipeline
The company agreed to acquire privately held Merida Biosciences for up to $2.875 billion in cash, including an upfront payment and milestone-based consideration.
Eli Lilly to buy Merdia Biosciences in a deal valued at up to $2.88 billion, indicating renewed focus on pipeline expansion
The acquisition, reported as worth as much as $2.88 billion, adds another chapter to Lilly’s ongoing buy-or-build approach as biotech rivals also compete for late-stage assets and platform-like capabilities.
Johnson & Johnson schedules investor call for third-quarter results on Oct. 13
The company will hold an investor conference call at 8:30 a.m. Eastern Time to discuss its third-quarter performance, according to a notice posted by Yahoo Finance.
Pfizer reaches confidential settlement in Depo-Provera litigation over alleged meningioma risk
The agreement covers multiple federal lawsuits involving its Depo-Provera contraceptive and claims of an increased risk of intracranial meningioma, according to a report.
Moderna takes August’s S&P 500 win as biotech momentum lifts MRNA shares
A Yahoo Finance review of monthly performance found Moderna leading the S&P 500 in August, rising about 158%, while Edison International finished last, down roughly 27%.
Eli Lilly CEO David Ricks frames its $25B spending push as a long-term bet beyond obesity
In a CNBC interview, Eli Lilly’s chief executive said the company’s recent deal and investment activity is aimed at extending the durability of its obesity franchise and using related technologies to target other diseases through the 2030s, while acknowledging that not every bet will succeed.
Eli Lilly investors weigh valuation after fresh FDA nod, analyst models show mixed picture
A recent market note points to an estimated 30% upside from discounted cash flow modeling, even as other valuation checks look less clear-cut after a new Food and Drug Administration approval.
Eli Lilly shares slide after report of a $2.9 billion acquisition
A market report said Eli Lilly unveiled a $2.9 billion deal tied to its Merida program, prompting investors to reassess near-term valuation and integration risks.
Healthcare’s best week since late June draws focus to a Moderna and Merck cancer trial
A rebound in healthcare equities in the week leading up to Aug. 21 traced back to trading momentum around clinical news tied to Moderna’s work and a Merck cancer study, according to a Yahoo Finance market recap.